By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Corthera 

1660 South Amphlett Boulevard
Suite 200
San Mateo  California  94402-2525  U.S.A.
Phone: 650-235-3555 Fax: 650-235-3579


SEARCH JOBS








Company News
Novartis Corporation (NVS) (JOBS) To Pay Corthera Up To $620M For Heart Drug Rights 12/23/2009 6:58:51 AM
Corthera's Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure 10/1/2009 10:44:51 AM
Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables 6/1/2009 8:35:43 AM
Results and Additional Analyses From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009 5/28/2009 11:20:18 AM
Corthera Release: Results From Study Show Promising Efficacy and Safety Results for Corthera's Relaxin in Acute Heart Failure 3/30/2009 8:20:12 AM
Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at American College of Cardiology 3/23/2009 11:19:10 AM
Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure 11/10/2008 8:52:50 AM
Corthera Top-Line Preliminary Data From Phase II/III Study of Corthera's Relaxin in Acute Heart Failure to be Presented in Satellite Symposium at American Heart Association Scientific Sessions 2008 11/3/2008 7:48:20 AM
University of Cincinnati First in US to Study Corthera's Relaxin for Heart Failure 7/8/2008 2:47:09 PM
Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure 1/8/2008 8:00:52 AM
12
//-->